Sustained viremia during highly active antiretroviral therapy with accelerated proviral DNA decay in the setting of infection with syphilis

AIDS

Volumn 17, Issue 14, 2003, Pages 2143-2145

  Padte, Neal ^a   Rowe, Leslie ^a   Hurley, Arlene ^a   Simon, Viviana ^a   Markowitz, Martin ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; BENZATHINE PENICILLIN; INDINAVIR; LAMIVUDINE; VIRUS RNA;

ADULT; CASE REPORT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYPHILIS; VIREMIA; VIRUS ACTIVATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0142125242     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200309260-00025     Document Type: Letter

References (10)

1. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, et al. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA 2001, 286:171-179.
2. Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, et al. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000, 97:10948-10953.
3. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 2002, 288:222-235.
4. Giron-Gonzalez JA, Lopez-Sanchez A, Elvira J, Perez E, Fernandez-Gutierrez C. Effect of patient adherence to antiretroviral therapy on CD4+ cell count, HIV-1 RNA, and serum concentrations of tumor necrosis factor and its soluble receptors. Eur J Clin Microbiol Infect Dis 2000, 19:852-858.
5. Brigido LF, Rodrigues R, Casseb J, Oliveira D, Rossetti M, Menezes P, Duarte AJ. Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS 2001, 15:587-593.
6. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med 2002, 347:731-736.
7. Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999, 340:1605-1613.
8. Simon V, Vanderhoeven J, Hurley A, Ramratnam B, Louie M, Dawson K, et al. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS 2002, 16:1511-1519.
9. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999, 282:1135-1141.
10. Kellogg DE, Sninsky JJ, Kwok S. Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction. Anal Biochem 1990, 189:202-208.